Cerqueira CG, de Andrade RC, Kalil JR, Aparício CL, Silva BD, Pamponet MM, da Silva NM, Pires SMA, Zollinger CC, Lisboa BP

Idioma: Ingles.
Referencias bibliográficas: 28
Paginas: 90-95
Archivo PDF: 80.58 Kb.

RESUMEN

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Cárdenas A, Ginès P, Uriz J, Bessa X, Salmerón JM, Mas A, Ortega R, et al. Renal failure after upper gastrointestinal bleeding in cirrhosis: incidence, clinical course, predictive factors, and short-term prognosis. Hepatology 2001; 34: 671-6.

2. Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruiz-del- Arbol L, Castells L, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999; 341: 403-9.

3. Follo A, Llovet JM, Navasa M, Planas R, Forns X, Francitorra A, Rimola A, et al. Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis. Hepatology 1994; 20: 1495-501.

4. Terra C, Guevara M, Torre A, Gilabert R, Fernández J, Martín-Llahí M, Baccaro ME, et al. Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: value of MELD score. Gastroenterology 2005; 129: 1944-53.

5. Cholongitas E, Calvaruso V, Senzolo M, Patch D, Shaw S, O’Beirne J, Burroughs AK. RIFLE classification as predictive of mortality in patients with cirrhosis admitted to the intensive care unit. J Gastroenterol Hepatol 2009; 24: 1639-47.

6. Cholongitas E, Senzolo M, Patch D, Shaw S, O’Beirne J, Burroughs AK. Cirrhotics admitted to intensive care unit: the impact of acute renal failure on mortality. Eur J Gastroenterol Hepatol 2009; 21: 744-50.

7. D’Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006; 44: 217-31.

8. Garcia-Tsao G, Parikh CR, Viola A. Acute kidney injury in cirrhosis. Hepatology 2008; 46: 2064-77.

9. Kamath P, Kim WR; Advanced Liver Disease Group. The model for endstage liver disease. Hepatology 2007; 45: 797-805.

10. Solà E, Ginès P. Renal and circulatory dysfunction in cirrhosis: current management and future perspectives. J Hepatol 2010; 53(6): 1135-45.

11. Kalil JR, Cerqueira LA, Barbosa DS, Kalil JR, Cerqueira LA, Barbosa DS, Motta MP, et al. Poor outcomes with treatment of hepatorenal syndrome type 1 with splanchnic vasoconstrictors and albumin: report of seven cases and review of the literature. Arq Gastroenterol 2009; 46: 214-8.

12. Fasolato S, Angeli P, Dallagnese L, Maresio G, Zola E, Mazza E, Salinas F, et al. Renal Failure and Bacterial Infections in Patients with Cirrhosis: Epidemiology and Clinical Features. Hepatology 2007; 45: 223-9.

13. Martín-Llahí M, Guevara M, Torre A, Fagundes C, Restuccia T, Gilabert R, et al. Prognostic importance of the cause of renal failure in patients with cirrhosis. Gastroenterology 2011; 140: 488-96.

14. Fernandez J, Navasa M, Gomez J, Colmenero J, Vila J, Arroyo V, Rodés J. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 2002; 35: 140-8.

15. Murray KF, Carithers RL Jr. AASLD practice guidelines: evaluation of the patient for liver transplantation. Hepatology 2005; 41: 1407-32.

16. Arroyo V, Ginès P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, Reynolds TB, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology 1996; 23: 164-76.

17. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, et al. Acute Renal Failure in Critically Ill Patients: A Multinational, Multicenter Study. JAMA 2005; 294: 813-8.

18. Schepke M, Appenrodt B, Heller J, Zielinski J, Sauerbruch T. Prognostic factors for patients with cirrhosis and kidney dysfunction in the era of MELD: results of a prospective study. Liver Int 2006; 26: 834-9.

19. Alessandria C, Ozdogan O, Guevara M, Restuccia T, Jiménez W, Arroyo V, Rodés J. MELD Score and Clinical Type Predict Prognosis in Hepatorenal Syndrome: Relevance to Liver Transplantation. Hepatology 2005; 41: 1282-9.

20. Montoliu S, Ballesté B, Planas R, Alvarez MA, Rivera M, Miquel M, Masnou H, et al. Incidence and prognosis of different types of functional renal failure in cirrhotic patients with ascites. Clin Gastroenterol Hepatol 2010; 8: 616-22

21. Salerno F, Gerbes A, Ginès P, Wong F, Arroyo V. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut 2007; 56: 1310-8.

22. Jenq CC, Tsai MH, Tian YC, Lin CY, Yang C, Liu NJ, Lien JM, et al. RIFLE classification can predict short-term prognosis in critically ill cirrhotic patients. Intensive Care Med 2007; 33: 1921-30.

23. Fang JT, Tsai MH, Tian YC, Jenq CC, Lin CY, Chen YC, Lien JM, et al. Outcome predictors and new score of critically ill cirrhotic patients with acute renal failure. Nephrol Dial Transplant 2008; 23: 1961-9.

24. Du Cheyron D, Bouchet B, Parienti JJ, Ramakers M, Charbonneau P. The attributable mortality of acute renal failure in critically ill patients with liver cirrhosis. Intensive Care Med 2005; 31: 1693-9.

25. Arabi Y, Ahmed QAA, Haddad S, Aljumah A, Al-Shimemeri A, et al. Outcome predictors of cirrhosis patients admitted to the intensive care unit. Eur J Gastroenterol Hepatol 2004; 16: 333-9.

26. Juneja D, Gopal PB, Kapoor D, Raya R, Sathyanarayanan M. Profiles and outcome of patients with liver cirrhosis requiring mechanical ventilation. J Intensive Care Med 2011; 24 [Epub ahead of print].

27. Austin MJ, Shawcross DL. Outcome of patients with cirrhosis admitted to intensive care. Curr Opin Crit Care 2008; 14: 202-7.

28. Das V, Boelle PY, Galbois A, Guidet B, Maury E, Carbonell N, Moreau R, et al. Cirrhotic patients in the medical intensive care unit: early prognosis and long-term survival. Crit Care Med 2010; 38: 2108-16.